Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety

British Journal of Pharmacology

Volumn 117, Issue 7, 1996, Pages 1443-1448

  Kennett, G A ^a   Bright, F ^a   Trail, B ^a   Baxter, G S ^a   Blackburn, T P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT2B receptor; 5 HT2C receptor; Anxiety; BW 723C86

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; CHLORDIAZEPOXIDE; SEROTONIN 2 ANTAGONIST; SEROTONIN 2B RECEPTOR; 1 (5 (2 THENYLOXY) 1H INDOL 3 YL)PROPAN 2 AMINE; 1-(5-(2-THENYLOXY)-1H-INDOL-3-YL)PROPAN-2-AMINE; ANXIOLYTIC AGENT; DRUG DERIVATIVE; INDOLE DERIVATIVE; N-(1-METHYL-5-INDOLYL)-N'-(3-PYRIDYL)UREA; SEROTONIN AGONIST; THIOPHENE DERIVATIVE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; DRUG INHIBITION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY; ANIMAL; ANIMAL BEHAVIOR; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CHLORDIAZEPOXIDE; DISEASE MODELS, ANIMAL; INDOLES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS; THIOPHENES; UREA;

EID: 0029670308     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15304.x     Document Type: Article

References (38)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A., 90, 408-412.
2. 2B receptors. Behav. Brain Res., (in press).
3. 2 receptor subtypes, a family reunited? Trends Pharmacol. Sci. 16, 105-110.
4. 3 antagonist, ondansetron in social phobia. ACNP Meeting abstract.
5. BILL, D.J., FORSTER, E.A., GREWAL, S.S. & FLETCHER, A. (1995). Functional antagonistic and anxiolytic effects of the 5-HT2C/2B receptor antagonist, SB 200646A, in rodents. Br. J. Pharmacol., 116, 217P.
6. 3 receptor antagonist with anxiolytic-like properties. Psychopharmacology, 110, 257-264.
7. CLINESCHMIDT, B.V., REISS, D.R., PETTIBONE, D.J. & ROBINSON. J.L. (1985). Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J. Pharmacol. Exp. Ther., 235, 696-708.
8. 1C receptors in the anxiogenic-like effects of fenfluramine in a modified Vogel conflict test. Br. J. Pharmacol., 106, 128P.
9. DAWSON, G.R., CRAWFORD, S.P., COLLINSON, N., IVERSEN, S.D. & TRICKLEBANK, M.D. (1995). Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology, 118, 316-323.
10. 28 receptor protein in the rat brain. Br. J. Pharmacol., 115, 105P.
11. FILE, S.E. & HYDE, J.R.G. (1978). Can social interaction be used to measure anxiety? Br. J. Pharmacol., 62, 19-24.
12. 2B receptor mRNA in rat brain. Br. J. Pharmacol., 114, 369P.
13. FOQUET, M., HOYER, D., PARDOE, L.A., PAREKH, A., KLUXEN, F.W., KALKMAN, H.O., STUHMER, W & LUBBERT, H. (1992). Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J., 11, 3481-3487.
14. 1C receptor antagonist. J. Med. Chem., 36, 1104-1107.
15. GELLER, I., KULAK, J.T. & SEIFTER, J. (1962). The effects of chlordiazepoxide and chlorpromazine on a punishment discrimination. Psychopharmacologia, 3, 374-385.
16. GELLER, I. & SEIFTER, J. (1960). The effects of meprobamate, barbituates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia, 1, 482-492.
17. 2C receptors but not by sympathomimetic effects. Neuropharmacology, 33, 457-465.
18. HANDLEY, S.L. & MITHANI, S. (1984). Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of fear-motivated behaviour. Naunvn-Schmied. Arch. Pharmacol., 327, 1-5.
19. 3 receptor antagonists. Psychopharmacology, 104, 545-551.
20. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
21. 3 receptor antagonist. Br. J. Pharmacol., 93, 985-993.
22. 1C receptors and their therapeutic relevance. Curr. Opin. Invest. Drugs, 2, 317-362.
23. 2B receptor antagonist in two conflict models of anxiety. Psychopharmacology, 118, 178-182.
24. 1C receptor antagonists. Eur. J. Pharmacol., 164, 445-454.
25. 2C/2B receptor antagonist. Br. J. Pharmacol., 111, 797-802.
26. KUHAR, M.J. (1986). Neuroanatomical substrates of anxiety: a brief survey. Trends Neurosci., 9, 307-311.
27. 2F) from rat stomach fundus. Mol. Pharmacol., 42, 549-557.
28. 2-like receptor. Expression in brain, heart and intestine. FEBS Lett., 312, 203-207.
29. 2C/2B antagonist SB 200646A in the conditioned emotional response model of anxiety in the rat. Br. J. Pharmacol., 116, 215P.
30. PELLOW, S., CHOPIN, P., FILE, S.E. & BRILEY, M. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods, 14, 149-167.
31. 3 receptor antagonists BRL 43694 and GR 38032F in animal models of anxiety. Br. J. Pharmacol., 94, 314P.
32. 2C receptors. Mol. Brain Res., 23, 163-178.
33. 28 serotonin receptor. FEBS Lett., 342, 85-90.
34. 7 receptors in guinea-pig brain. Br. J. Pharmacol., 115, 107-116.
35. 3 antagonists in laboratory animals. Neurosci. Lett., 29 (suppl. 1), 68-77.
36. 4 receptor with high affinity for the antipsychotic clozapine. Nature, 350, 610-614.
37. WHITTON, P. & CURZON, G. (1990). Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. Psychopharmacology, 100, 138-140.
38. YADIN, E., THOMAS, E., GRISHKAT, H.L. & STRICKLAND, C.E. (1993). The role of the lateral septum in anxiolysis. Physiol. Behav., 53, 1077-1083.